Shares of Gland Pharma rallied on Monday after the company reported a 97% YoY surge in Q4 profit and strong revenue growth, driven by its CDMO business. The board also announced a ₹20-per-share final dividend for FY26, boosting investor sentiment.
Recent Posts
- Crypto traders betting on a rally lose $563 million in liquidations. Ether and bitcoin suffer the most
- Ryanair has plans for ‘armageddon’ scenario as CFO warns weaker European carriers may not survive jet fuel crunch
- Stock Market Crash News Today Live Updates: Nifty Reclaims 23,450, Sensex Gains 500 Points From Day’s Low; IT Stands Out As Only Sectoral Gainer
- Cochin Shipyard Shares Tumble 7% As Kotak Eyes 43% Downside After Q4 Profit Drop: Buy Or Sell?
- Messi Fiasco: New BJP Govt In Bengal Orders Probe, Says Event Tickets May Be Refunded